Tagged with

Perrigo Store brands are Perrigo’s core business. The vice president and managing director of the Mexican and Latin American affiliate discusses the company’s pioneer and early vision to bet on generics and store brands in a market dominated by branded drugs, the investments the company has undertaken in Mexico to double…

FDA Chung Seung, Minister of Food and Drug Safety, discusses the latest improvements to Korea’s regulatory system and highlights vaccines, biosimilars and stem cell research as key components of the country’s pharmaceutical sector.   What are the primary goals of the ministry today? Since the Ministry of Food and Drug Safety…

investment The head of the government agency charged with attracting and promoting FDI in Korea discusses how the country has ideally positioned itself between China and western markets through a series of free trade agreements, and the climate for investment in the life science sector.   Compared to previous years, how…

immunology The executive director of the university spin-off UDIMEB explains the major achievements of the institution, her plans to convert it into a strategic partner to the pharmaceutical and biotechnology industry to conduct pre-clinical tests and the challenges spin-off initiatives face today in Mexico.     In the past pharmaceutical R&D activities…

Conference The director of Algeria’s only pharmaceutical fair speaks out about how he came to set up the event and how the local industry has evolved over time.   Where did the idea for Siphal come from, and what challenges have you had to address? I went to pharmacology school in…

Janssen Janssen’s managing director in Korea discusses the groups long and significant commitment to R&D in the country, as well as some of the challenges that one of the most innovative multinational companies must face in a market that has traditionally been reluctant to recognize the value of highly innovative products.…

Ferring The country manager of a research-driven, specialty biopharmaceutical group offering treatments for infertility outlines his firm’s approach for the socially conservative Algerian market. Your promotion as general manager of Ferring Algeria is quite recent. Can you tell us what were your priorities during the first year and how do you…

PwC The partner and leader of the healthcare practice for Mexico and Hispanic America shares his vision about how Mexico’s healthcare sector is converging to look at innovative ways to understand how health impacts on the economic growth of the country.     Back in 2012 you told us that the…

access Healthcare should not be seen as an expenditure, but rather as an investment. Mexico’s former minister of health and current dean at the Harvard T.H. Chan School of Public Health discusses how Mexico is moving towards effective universal coverage, the challenges the system is facing and the issues that remain.…

medical devices Mr Carlos Jimenez of B. Braun Aesculap sat down with us and shared his personal beliefs on Mexico’s market potential for medical equipment, how the country can create more momentum for the healthcare industry and the ethics and ethos of the company. What have been your milestones and challenges since…

stem cell The founder of MEDIPOST, the producer of the only approved allogenic stem cell product in the world, disucsses their development goals for the coming years and the potential for regenerative medicine to revolutionize a variety of healthcare practices. Dr. Yang, to begin, could you please introduce yourself and MEDIPOST to…

R&D Gador’s first general director from outside of the family discusses his mission, Gador’s key to success, and his method for successfully leading a company in Argentina’s unpredictable and volatile market. What was the mission that you were given when you were made the general director? This is the first time…